Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that involves different organs. Its most important feature is the production of specific autoantibodies against nuclear or cytoplasmic antigens. Proteomic analysis of serum, as one of the most readily available body fluids, can be used as a method for clarifying the pathogenesis of SLE. In this study the serum proteome of 13 patients with SLE was evaluated and compared with seven healthy control participants. A specific kit was used to remove high-abundance proteins. After depletion, the protein expression patterns created by two-dimensional gel electrophoresis (2-DE) and MALDI-TOF/TOF-MS were used to identify disease-associated proteins. We found differential expression of 15 protein spots, including seven up-regulated and eight down-regulated proteins in SLE samples, in comparison with healthy participants. These spots were identified by MALDI-TOF/TOF-MS and classified into three groups include keratins, apolipoproteins and albumin, and individual proteins such as transthyretin, haptoglobin and prothrombin. These findings can help to clarify the pathophysiology and mechanism of SLE.
BauerJWBaechlerECPetriM. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Medicine2006; 3: e491–e491.
4.
RahmanAIsenbergDA. Systemic lupus erythematosus. N Engl J Med2008; 358: 929–939.
5.
ProkuninaLCastillejo-LopezCObergF. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nature Genet2002; 32: 666–669.
6.
HanGMChenSLShenNYeSBaoCDGuYY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immunity2003; 4: 177–186.
7.
DaiYHuangYSTangM. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus2007; 16: 939–946.
8.
KalenkaAFeldmannREOteroKMaurerMHWaschkeKFFiedlerF. Changes in the serum proteome of patients with sepsis and septic shock. Anesthes Analges2006; 103: 1522–1526.
9.
HuSLooJAWongDT. Human body fluid proteome analysis. Proteomics2006; 6: 6326–6353.
10.
TirumalaiRSChanKCPrietoDAIssaqHJConradsTPVeenstraTD. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics2003; 2: 1096–1103.
11.
BradfordMM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem1976; 72: 248–254.
12.
AhmedNBarkerGOlivaK. An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics2003; 3: 1980–1987.
13.
KazemipourNCondemineGHugouvieux-Cotte-PattatN. The secretome of the plant pathogenic bacterium Erwinia chrysanthemi. Proteomics2004; 4: 3177–3186.
14.
BeutlerEGelbartTLeeP. Haptoglobin polymorphism and iron homeostasis. Clin Chem2002; 48: 2232–2235.
15.
AhmedNBarkerGOlivaKT. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer2004; 91: 129–140.
16.
PavonEJMunozPLarioA. Proteomic analysis of plasma from patients with systemic lupus erythematosus: Increased presence of haptoglobin α2 polypeptide chains over the α1 isoforms. Proteomics2006; 6: S282–S292.
17.
Van VlierbergheHLangloisMDelangheJ. Haptoglobin polymorphisms and iron homeostasis in health and in disease. Clin Chim Acta2004; 345: 35–42.
18.
BreslowJLRossDMcPhersonJ. Isolation and characterization of cDNA clones for human apolipoprotein A-I. Proc Natl Acad Sci U S A1982; 79: 6861–6865.
19.
WasanKMBrocksDRLeeSDSachs-BarrableKThorntonSJ. Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: Implications for drug discovery. Nat Rev Drug Discov2008; 7: 84–99.
20.
WilhelmAJZabalawiMGraysonJM. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol2009; 29: 843–849.
21.
BresnihanBGogartyMFitzGeraldODayerJMBurgerD. Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: A control mechanism of cytokine production?Arthritis Res Ther2004; 6: 563–566.
HykaNDayerJMModouxC. Apolipoprotein A-I inhibits the production of interleukin-1{beta} and tumor necrosis factor-{alpha} by blocking contact-mediated activation of monocytes by T lymphocytes. Blood2001; 97: 2381–2389.
24.
McMahonMGrossmanJFitzGeraldJ. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum2006; 54: 2541–2549.
25.
NelsonDLLehningerALCoxMM. Lehninger principles of biochemistry, 5th ed. New York, USA: Macmillan, 2008, pp. 1294–1294.
26.
GaoWMKuickROrchekowskiRP. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer2005; 5: 110–110.
27.
GerickeBRailaJSehouliJ. Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. BMC Cancer2005; 5: 133–133.
28.
ZhangZBastRCJYuY. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res2004; 64: 5882–5890.
29.
RanaAMinzRWAggarwalR. A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS–A pilot study. Pediatr Rheumatol2012; 10: 24–32.
30.
KorteEAGaffneyPMPowellDW. Contributions of mass spectrometry-based proteomics to defi ning cellular mechanisms and diagnostic markers for systemic lupus erythematosus. Arthritis Res Ther2012; 14: 204–214.
